Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence.
Treatment of onychomycosis is associated with substantial disease reappearance rates. Identification of factors associated with therapeutic failure may help develop strategies to prevent recurrence of onychomycosis. Aspects of a patient's health and lifestyle, local factors involving the nail, therapeutic options, and environmental conditions are associated with poor therapeutic response. Strategies to reduce recurrence of disease involve the reduction of both relapse (delayed failure) and reinfection. The topical antifungal agent ciclopirox nail lacquer, may be a consideration for prophylaxis of this chronic disease.
Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), the University of Toronto, Canada.
Aditya K
AK
Gupta
Lindsay E
LE
Lynch
D000935:Antifungal Agents / Q000627:therapeutic use; D006801:Humans; D006920:Hygiene; D008019:Life Style; D014009:Onychomycosis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D011379:Prognosis; D012307:Risk Factors; D055502:Secondary Prevention
D000935:Antifungal Agents